Opinion & analysis | Page 2 of 10 | Report Store

Pharma Intelligence

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 - 12 St. James's Square, London, England, SW1Y 4LB. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Call Back

Name

Email *

Company name *

Phone number *

GSK’s Hal Barron On R&D Progress At TwoYear Mark

The Case For Agile Innovation In Health Care

Roche: We’ve Abandoned Budgets And It’s Liberated Employees

MorphoSys: A European Champion Crossing The Biopharma Rubicon

Can Novartis Reclaim Pioneering Role In Transplantation?

Defying FDA: Shanghai Lab Gets Warning Letter But Won’t Relent

Nitrosamine Episode Could Lead To Paradigm Shift In Quality

Countdown To Transition: US FDA Says 91 Drugs Will Become Biologics In March 2020

EMA under Pressure again as Staff Losses Worsen

US FDA’s Temple on Real-world Evidence: “I Find the Whole Thing Very Frustrating”

86% Rise In GMDN Usage Heralds New Era Of Postmarket Data Analytics

US House Panel Approves Medicare Hearing, Dental And Vision Coverage; Senate Bill Introduced

Six Key New Commission Documents Relating To EU Directives And New Regulations

Drug/Device Combinations: Shock For Pharma As It Seeks Notified Body Resources Too

Abbott Launches New App To Keep Heart Failure Patients Out Of The Hospital

Eight Talking Points from ESMO

Ranbaxy Brothers Arrested, Downward Spiral Intensifies

Culture Change At GSK: ‘We’re Doing What We Said We’d Do’

Sanofi’s New CEO Paul Hudson Poised To Write The Next Chapter

Amarin CEO Thero On Gearing Up For Success Ahead Of The Big Vascepa Ad Comm

Schakowsky’s Loaded Cosmetics Bill Described as ‘Floor, Not a Ceiling’ for States to Build On

A Hangover Is A Disease, German Court Rules

Serious Skin Reactions Reported with Ibuprofen Use in Europe

Anti-Aging Cosmetics Or Unlawfully Marketed Drugs? Two Federal Court Cases To Watch

Testing Ranitidine with Too Much Heat Could Generate NDMA, FDA Say

How To Pay For The New Wave Of Gene Therapies

Farxiga Data Change Heart Failure Treatment Outlook

ESMO Preview: Five Key Oncology Battlegrounds To Watch

Novo Nordisk’s Oral Rybelsus Priced On Par With Injectable GLP-1s, But Big Discounts May Be Needed

Roche: We’ve Abandoned Budgets And It’s Liberated Employees